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Abstract
Background: Transcription factors (TFs) and microRNAs (miRNAs) are primary metazoan gene regulators. Regulatory
mechanisms of the two main regulators are of great interest to biologists and may provide insights into the causes of
diseases. However, the interplay between miRNAs and TFs in a regulatory network still remains unearthed. Currently, it
is very diﬃcult to study the regulatory mechanisms that involve both miRNAs and TFs in a biological lab. Even at data
level, a network involving miRNAs, TFs and genes will be too complicated to achieve. Previous research has been
mostly directed at inferring either miRNA or TF regulatory networks from data. However, networks involving a single
type of regulator may not fully reveal the complex gene regulatory mechanisms, for instance, the way in which a TF
indirectly regulates a gene via a miRNA.
Results: We propose a framework to learn from heterogeneous data the three-component regulatory networks, with
the presence of miRNAs, TFs, and mRNAs. This method ﬁrstly utilises Bayesian network structure learning to construct
a regulatory network from multiple sources of data: gene expression proﬁles of miRNAs, TFs and mRNAs, target
information based on sequence data, and sample categories. Then, in order to produce more meaningful results for
further biological experimentation and research, the method searches the learnt network to identify the interplay
between miRNAs and TFs and applies a network motif ﬁnding algorithm to further infer the network.
We apply the proposed framework to the data sets of epithelial-to-mesenchymal transition (EMT). The results
elucidate the complex gene regulatory mechanism for EMT which involves both TFs and miRNAs. Several discovered
interactions and molecular functions have been conﬁrmed by literature. In addition, many other discovered
interactions and bio-markers are of high statistical signiﬁcance and thus can be good candidates for validation by
experiments. Moreover, the results generated by our method are compact, involving a small number of interactions
which have been proved highly relevant to EMT.
Conclusions: We have designed a framework to infer gene regulatory networks involving both TFs and miRNAs from
multiple sources of data, including gene expression data, target information, and sample categories. Results on the
EMT data sets have shown that the proposed approach is able to produce compact and meaningful gene regulatory
networks that are highly relevant to the biological conditions of the data sets. This framework has the potential for
application to other heterogeneous datasets to reveal the complex gene regulatory relationships.
Background
The regulation of gene expression is a critical mechanism
in the control of biological processes in cellular organisms.
At the transcriptional level, the main regulators contribut-
ing to the control are transcription factors (TFs), proteins
that bind to cis-regulatory elements in the gene promoter
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regions [1]. By activating or repressing their target genes,
TFs can regulate the global gene expression program of a
living cell, and form transcriptional regulatory networks
[2-4].
Recent studies have identiﬁed that microRNAs
(miRNAs) play an important role in gene regulation at the
post-transcriptional level. The regulation process takes
place via mRNA cleavage or translational repression, with
miRNAs binding to the 3’-untranslated regions (3’-UTRs)
of target mRNAs through base pairing to complemen-
tary sequences [5-8]. It has also been demonstrated in a
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body of literature that miRNAs regulate a wide range of
biological processes in proliferation [9,10], metabolism
[11,12], diﬀerentiation [13], development [14,15], apop-
tosis [12,16,17], cellular signaling [18] and even cancer
development and progression [7,19,20].
It is necessary to draw a uniﬁed picture for the reg-
ulatory relationships between TFs, miRNAs and genes.
However, a challenge is that the combined regulations
of miRNAs and TFs are complicated, since they involve
not only the interactions between each regulator and
their target genes, but also the interactions between the
regulators themselves. Studies of the gene regulatory net-
works with the presence of both TFs and miRNAs will
help elucidate the regulatory mechanisms involving both
direct and indirect regulatory relationships. However, It
is still highly unlikely for these relationships to be dis-
covered by biological experiments directly, as the process
would be extremely costly and time consuming. On
the other hand, well-designed computational approaches
may facilitate the understanding of such complex
relationships.
Previously, researchers studied the co-regulation of TFs
and miRNAs by ﬁnding out their shared downstream tar-
gets [21,22]. The methods used probabilistic models or
statistical tests to measure the signiﬁcance of the shared
targets between the regulators, and to remove the insignif-
icant co-regulating interactions that occurred by chance.
Gene enrichment analysis was used in [23] to identify
signiﬁcant co-regulation between the transcriptional and
post-transcriptional layers. They found that some bio-
logical processes emerged only in co-regulation and that
the disruption of co-regulation may be closely related to
cancers, suggesting the importance of the co-regulation
of miRNAs and TFs. In [23] available predicted targets
databases are used to construct the network, and then
Gene Ontology (GO) was used to discover the signiﬁcant
functional co-regulation pairs. Tran et al. [24] proposed a
rule based method to discover the gene regulatory mod-
ules that consist of miRNAs, TFs, and their target genes
based on the available predicted target binding informa-
tion. Le Be´chec et al. [25] integrated available target pre-
diction databases to construct a regulatory network that
involves miRNAs, TFs, and mRNAs. This work provides
a good resource for exploring the regulatory relationships
or identifying the network motifs. However, target predic-
tion based on sequences have high rate of false discoveries,
which aﬀect the quality of the discoveries of the above
mentioned methods. It would be ideal if expression data
can be used to reﬁne the discoveries.
Roqueiro et al. [26] proposed a method to identify
the key regulators (miRNAs or TFs) of pathways. The
method used Bayesian inference on known pathway struc-
tures to infer a set of regulators in the pathway network.
The Bayesian network in this method was constructed
manually using the known KEGG pathways by remov-
ing the cycles in the pathways and applying some ﬁltering
criteria. The method drew ﬁndings based on existing
knowledge and provided a good resource for other meth-
ods to validate their results. However, it may not be good
for exploratory study.
Recently, Huang et al. [27] developed a web tool
(mirConnX) for constructing the regulatory networks that
include miRNA, TFs, and mRNAs. The built networks
can be further analysed to identify network motifs. The
method has used both predicted targets and expression
data to build the network. The method integrated the
association network based on expression data and the
prior network based on sequence data. However, an edge
in this network shows association, which may not indi-
cate a regulation relationship. A strong association of A
and B may be a result of a common regulator which regu-
lates both A and B. Zacher et al. [28] proposed a Bayesian
inference method based on expression data to explain the
activity of miRNAs and TFs. However, this approach does
not take into account the interactions between miRNAs
and TFs.
In this paper, we present a framework to construct the
complex regulatory network with three components: TFs,
miRNAs, and target genes. Our approach aims to dis-
cover the regulatory relationships of miRNAs and TFs
on their target genes respectively, as well as the interplay
between the two diﬀerent types of regulators. Themethod
utilises multiple sources of data, including gene expres-
sion data, target information of each regulator based on
sequence data, and sample categories (conditions). To test
the proposed method, we use the expression data from
the NCI-60 panel of cell lines [29], and investigate the




Consider three expression data sets proﬁling K miRNAs,
I TFs, and J mRNAs across S samples, respectively. Let
x = {xk}, y = {yi}, z = {zj} be the vectors of miRNAs, TFs,
and mRNAs, respectively, where 1 ≤ k ≤ K , 1 ≤ i ≤ I,
and 1 ≤ j ≤ J . Each sample is labelled by its category, i.e.
the biological condition of the samples, such as cancer or
normal.
In this paper, our goal is to discover the interactions
between x, y, z (x and y are regulators) supported by the
expression data and under the constraint of target infor-
mation (see Figure 1). Target information for a regulator is
the interactions between the regulator and the regulated
genes that are predicted based on the sequence data. We
are particularly interested in the interactions between x
and y (called the interplay of miRNAs and TFs), and net-
work motifs, which are patterns of subgraphs that recur at
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Figure 1Method overview. The method utilises Bayesian network learning and graph search to produce a three-component regulatory network
(miRNA-TF-mRNA) from multiple sources of data. Target information is used to create the initial structure representing the interactions between
miRNA-mRNA, miRNA-TF, TF-miRNA, TF-TF, and TF-mRNA. For illustration, we only draw one bipartite graph in the initial structure. Expression
proﬁles are then used in the Bayesian network learning procedure to construct the networks in each sample condition. Bootstrapping and
averaging procedure is used to integrate the Bayesian networks learnt from each condition into the integrated global network. The interplays
between miRNAs and TFs and the network motifs that involve at least 2 regulators are extracted from the global network and are ﬁnal results.
frequencies much higher than those found in randomised
networks [2].
Method overview
In the remaining parts of the Methods section, we
present our framework for constructing the regulatory
network with the co-existence of both regulators, TFs
and miRNAs. The method aims to produce regulatory
networks including miRNAs, TFs, and genes that are
relevant to diseases. The overall process is shown in
Figure 1.
There are three main steps in the framework: (1)
data preparation, (2) network learning and integration,
and (3) network inferences. In Step (1), we prepare
the input for the network structure learning, includ-
ing collecting target information for TFs and miRNAs,
normalising expression data, and analysing diﬀerentially
expressed genes. At the beginning of Step (2), the target
information is transformed into the 5 types of network
sub-structures (miRNA-mRNA, miRNA-TF, TF-miRNA,
TF-TF, and TF-mRNA), which are used as the ini-
tial structure for the Bayesian network learning process
(refer to Figure 1). Additionally the expression datasets
are split according to sample conditions. The initial
structure are evaluated based on the expression pro-
ﬁles in each condition. The Bayesian networks learnt
under each condition are integrated using a bootstrap-
ping and averaging procedure. Therefore the result of Step
(2) is an integrated global network with three compo-
nents: miRNAs, TFs, and mRNAs. In the network infer-
ence step (Step (3)), we search the global network for
the subgraphs that show the interplay between miRNAs
and TFs, and network motifs that involve at least two
regulators.
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In the following, we describe each of the three steps in
detail.
Step (1): Data preparation
Epithelial-to-mesenchymal transition (EMT) is part of the
process of tissue remodeling during embryonic develop-
ment and wound healing [30], and during carcinogenesis
[31] when cancer cells undergo a change transforming into
a more invasive tumor [30,32].
After EMT induction, cells lose their epithelial features
characterised by the high E-cadherin expression level, and
acquire mesenchymal characteristics, including Vimentin
ﬁlaments and a ﬂattened phenotype. By expressing pro-
teases, cells become more invasive, and they can pass
through the underlying basement membrane and migrate.
These are crucial steps in the multistep process of metas-
tasis [33].
Data used in this study contain miRNA expression pro-
ﬁles for the NCI-60 panel of 60 cancer cell lines obtained
from Sø et al. [34] (available at [http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE26375]). The mRNA
expression proﬁles for NCI-60 are downloaded from
ArrayExpress [http://www.ebi.ac.uk/arrayexpress], acces-
sion number E-GEOD-5720. Cell lines categorised as
epithelial (11 samples) and mesenchymal (36 samples) are
used in this work.
In order to identify all the TF genes in the data sets, we
use the list of TF repertoire mined from [1]. This list is
then used to query against the mRNA expression proﬁles
from NCI-60 to extract TF expression proﬁles.
After normalising the expression data of miRNAs, TFs,
and mRNAs, diﬀerentially expressed gene analysis is con-
ducted respectively to all the three components, TFs,
miRNAs, and mRNAs. The diﬀerentially expressed genes
between epithelial and mesenchymal samples are identi-
ﬁed using the limma package of Bioconductor [35] with
the Benjamini and Hochberg’s (BH) correction method
[36]. 148 probes of TFs, and 2251 probes of mRNAs are
identiﬁed as diﬀerentially expressed at signiﬁcant levels
(adjusted p-value< 0.1). Also 43 probes of miRNAs are
identiﬁed with adjusted p-value< 0.01. The reason for
choosing adjusted 0.01 as the cut-oﬀ for miRNA diﬀeren-
tially expressed analysis is that the B statistic value out-
put from limma changes the value signiﬁcantly between
adjusted p-value< 0.01 and adjusted p-value> 0.01. This
is a good sign for using the value of 0.01 as a cut-oﬀ,
and the number of miRNAs obtained with this cut-oﬀ is
also reasonable for analysing the results. (The details of
diﬀerentially expressed genes are in Additional ﬁle 1).
The data input to the Bayesian network learning in
the next step is the expression proﬁles of three com-
ponents, miRNAs, TFs, and mRNAs. To integrate the
data proﬁled from diﬀerent platforms, we discretise the
expression values of each gene in each sample to binary
values (standing for up-regulation and down-regulation)
by using the median of each array as the cut-oﬀ.
Another input to the Bayesian network learning is the
target information, which is used as the prior knowl-
edge (initial Bayesian network structure) to reduce the
search space in the learning. miRNA targets and TF tar-
gets are collected via commonly used databases. These
databases usually predict target genes using sequence
data. In this paper, we are particularly interested in the
information of TFs targeting both mRNA and miRNA
genes, and the miRNAs targeting mRNA and TF genes.
We use TRANSFAC 9.3 [37] and the promoter database
[38] to generate TF target information. TF target infor-
mation for TF-mRNA and TF-TF pairs is obtained from
CRSD [39], the database utilising and integrating six well-
known large scale databases, including TRANSFAC 9.3
and promoter databases. To obtain the TF-miRNA tar-
get information, we use MIR@NT@N downloaded from
[25]. Meanwhile miRBase V5.0 [40] from the Bioconduc-
tor package RmiR.Hs.miRNA 2.11 is used to build the
putative target for miRNAs. The detailed results of all
target information are shown in the Additional ﬁle 2.
Step (2): Bayesian networks structure learning and
integration
Bayesian network structure learning has been widely used
for discovering gene-gene interaction networks [41], but
not often for the discoveries of the interactions between
regulators and their target genes. To represent the interac-
tions between regulators (miRNAs and TFs) and between
the regulators and their target genes in a Bayesian net-
work, regulators and target genes are denoted by nodes
and regulatory interactions are denoted by directed edges.
When the expression data of regulators and target genes
are given, we can use Bayesian network structure learning
to discover the interactions. To start the learning process,
we use the target information of regulators to initialise the
search space. Therefore in this step, we take the expression
proﬁles and target information as the input to produce a
network that indicates the interactions between miRNA-
TF, miRNA-mRNA, TF-miRNA, TF-TF, and TF-mRNA.
The following four sub-steps are carried to obtain the
network.
Step (2.1): Sample splitting
To explore all possible interactions including up-, down-,
and mix- regulations (up-regulation in one condition and
down-regulation in the other) in diﬀerent biological con-
ditions, in [42] we developed the “splitting and averaging”
strategy for Bayesian networks structure learning. This
strategy splits samples in a data set by their categories of
biological conditions. Bayesian network structure learn-
ing is used to learn the networks from the samples of
each condition respectively, and these networks are then
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integrated or averaged into a single network. In our cur-
rent problem, we ﬁrstly use this strategy to learn the
networks for the epithelial and mesenchymal conditions
separately, then obtain the integrated network from the
networks learnt under the two conditions. So in this sub-
step, we split each of the three expression datasets accord-
ing to sample conditions, 11 samples in epithelial and 36
samples in mesenchymal (conditions 1 and 2 in Figure 1
respectively).
Step (2.2): Creating the initial structure
To learn a Bayesian network with n variables or nodes,
the search space, if not restricted, will be all the possible
networks formed with the variables. It has been shown
that ﬁnding the best network from all the networks is NP-
hard [43]. Therefore in this paper, we assume that the
regulatory relationships between regulators and their tar-
get genes form a bipartite graph. This assumption reduces
the search space signiﬁcantly. Moreover, we use target
information to initialise the network structure and the
topology of the network structure is further constrained.
Therefore, we are able to discover the optimal solutions
using the exhaustive search method in the given search
space. Graphically, the target information can be repre-
sented using bipartites as illustrated in Figure 1. There are
5 types of such bipartites or sub-structures, corresponding
to our initial knowledge of the interactions of miRNA-
TF, miRNA-mRNA, TF-TF, TF-miRNA and TF-mRNA.
These bipartites are used as the initial structure for the
Bayesian network learning.
Step (2.3): Bayesian network learning process
Each interaction in the initial structure is evaluated based
on the expression data, and the high-conﬁdence interac-
tions are retained. The learning process searches through
all possible candidate structures and evaluates the inter-
actions with a Bayesian scoring function. The candidate
structures are generated by removing edges from the ini-
tial structure one by one. The scoring function measures
the degree of ﬁtness of any candidate structure G to the
dataset. The goal is to select the structure that best ﬁts the
data. In other words, we need to calculate the probability
of each candidate structure G given the data D, P(G|D).
According to Bayes’ theorem, we have:
P(G|D) = P(G)P(D|G)P(D)
In the above formula, the term P(D) is the same for
all candidate structures. Regarding the term P(G), it is
quite common to assume a uniform distribution [44], and
thus it is a constant. Therefore, for comparative purposes,
it is suﬃcient to calculate only P(D|G) for the scoring
function. In this paper, we use the BDe (Bayesian metric
with Dirichlet priors and equivalent) scoring function
developed by Heckerman et al. [45] in the following.










(a(G)ijk + s(G)ijk )
(a(G)ijk )
where:
n is the number of variables (nodes), X1,X2, . . . ,Xn,
qi is the number of diﬀerent instantiations of the
parent of a variable Xi in G,
ri is the number of possible values of Xi in G,
Figure 2 An example of Bayesian network structure learning. (a) The initial structure corresponding to regulator R1 and target gene G1.
This initial structure is created based on target information of the regulator. (b) All possible candidate structures generated from the initial structure.
The interaction between R1 and G1 in each candidate structure is evaluated using a scoring function. (c) The presence or absence of an edge
between R1 and G1 based on the average score of each case. The candidate structure with higher average score will be chosen.
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a(G)ijk are the hyperparameters for the Dirichlet prior
distributions of the parameters given the network
structure.












More details of the Bayesian scoring function can be
found in [45,46]. In practice, we use the Bayes Net tool-
box for Matlab (BNT) [47], and the BDe scoring function
is included in BNT. In the next step (Step (2.4)) we eval-
uate the conﬁdence levels of the interactions output from
the Bayesian network structure learning.
For illustration purpose, consider the learning proce-
dure for the interaction between a regulator R1 and its
target gene G1. Assume that in total R1 has two targets
and the corresponding initial structure is in Figure 2a. The
interactions in each of the four possible candidate struc-
tures (see Figure 2b) can be evaluated with the scoring
function based on expression data. The scores will decide
if there is no edge between R1 and G1 or an edge between
them. In this example, there are two structures with an
edge between R1 and G1, and two structures with no edge
between them. The average score in each of the two cases
is calculated and the structure with higher average score
((-4.6-6.2)/2=-5.4) is chosen (Figure 2c).
Step (2.4): Integrating and bootstrapping
It is common to have small number of samples in the
dataset of a typical microarray experiment, which unfor-
tunately cannot support statistically signiﬁcant discov-
eries. To overcome this problem, bootstrapping [48] is
usually used to improve the conﬁdence of discoveries.
Especially, in Bayesian network structure learning, boot-
strapping can be combined withmodel (structure) average
procedure to discover the interactions with high conﬁ-
dence. In this paper, the averaging procedure is ﬁrstly
applied to the Bayesian network learning process across
diﬀerent candidate structures. This procedure is then
applied to the sample splitting step across diﬀerent sam-
ple conditions to calculate the average score for each
interaction. Next, the score of each interaction is aver-
aged over the number of bootstrapping, and the conﬁ-
dence levels are estimated based on a statistical model
as illustrated in the next paragraph. The interactions
with high conﬁdence (p-value< 0.05) are selected to
Figure 3 The interplays between TFs andmiRNAs - miRNAs regulate TFs.miRNAs are coloured in red and TFs are in green. The conﬁrmed
edges are highlighted with bold lines. All of the nodes in the conﬁrmed interactions are EMT bio-markers. They are the miR-200 family, ZEB1, ZEB2,
and SNAI2 (SLUG). The miR-200 family that regulates ZEB1, ZEB2 for EMT has been conﬁrmed by literature.
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form the integrated network (called global network in the
paper)
Consider again the example about learning the inter-
action between R1 and G1. Let n be the number of
bootstrapping iterations, qc be the event of learning the
interaction on the local data set Dc of the cth condition
(c ∈ {1, . . . ,C}). As there are only two possible cases
of interactions between R1 and G1, we approximate the
whole learning process of the interaction between R1 and
G1 as a Bernoulli experiment. We denote qc = 1 when
there is an edge between R1 and G1 (otherwise qc = 0),
and assume that p(qc = 1) = p(qc = 0) = 0.5. qc fol-
lows a binomial distribution qc ∼ B(n, p), as the samples
drawn with replacement in the bootstrap are independent
[49]. At the integration stage by averaging, the interac-
tions from local data sets Dc are aggregated, and the
interactions of the regulator R1 and its target G1 learnt
through multiple data sets for the C diﬀerent conditions
(denoted as QR1G1 =
∑
c qc) also follows a binomial
distribution QR1G1 ∼ B(Cn, p). Adopting this statisti-
cal model, we are able to extract the learnt interactions
at signiﬁcant levels. The interaction that has the conﬁ-
dence level greater than the threshold will be included
into the integrated global network. The Matlab codes
for the whole process is available on request, and the
results for the integrated global network is in Additional
ﬁle 3.
Step (3): Network inference
A challenging problem of Bayesian network learning is the
complexity of the resulting networks. Bayesian network
learning usually produces a large number of interactions,
including false discoveries. In this step, we extract from
the global network learnt in the previous step the interplay
between miRNAs and TFs. We search the learnt global
network for all of the interactions between miRNAs and
TFs. The resulting interplay network will help elucidate
the complex regulatory mechanism in speciﬁc biological
conditions.
In addition to discovering the interplay between miR-
NAs and TFs, we use the network motif ﬁnding algorithm,
Cyclus3D [50], to discover the network motifs that involve
at least 2 regulators. Network motifs are patterns of sub-
graphs that recur at frequencies much higher than those
found in randomised networks [2]. The randomised net-
works satisfy the following criteria: 1) they have the same
number of nodes as in the real network, 2) each node in
a randomised network has the same number of incom-
ing and outgoing edges as the corresponding node has
in the real network, 3) the randomised networks used to
Figure 4 The interplays between TFs andmiRNAs - TFs regulate miRNAs. The conﬁrmed edges are highlighted with bold lines. All of the nodes
in the conﬁrmed interactions are EMT bio-markers. SNAI2 (SLUG) regulates miR-200 family to indirectly control ZEB1 and ZEB2 for activating EMT
regulation procedure. These interactions have been conﬁrmed by literature.
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calculate the signiﬁcance of n-node subgraphs were gen-
erated to preserve the same number of appearances of
all (n − 1)-node subgraphs as in the real network. These
criteria ensure the randomised networks have the similar
structure to the real network, and ensure that a high-
signiﬁcance pattern is assigned not because it has a highly
signiﬁcant sub-pattern [2].
The resulting motifs can be considered as simple build-
ing blocks from which the network is composed [51], and
are believed to have speciﬁc functions which play criti-
cal roles in biological network inference [52]. The results
presented in the next section show that this network
inferences step can produce a set of interactions and
molecules which are highly relevant to the biological con-
dition of the EMT datasets.
Results
The output of the method are two types of networks:
1) the interplays between miRNAs and TFs, with their
details shown in Figure 3 and Figure 4; 2) the results
of network motif ﬁnding, which are the Feed For-
ward Loops (FFLs) that involve at least two regulators
(see Figure 5).
From Figures 3, 4, and 5, we can see that the results
generated by our method are compact with only a small
number of interactions. These interactions have been
shown to be highly relevant to the biological conditions
of EMT, and also several EMT bio-markers which have
been conﬁrmed by literature are identiﬁed by our method.
In the rest of this section, ﬁrstly we present the inter-
actions and bio-markers that have been conﬁrmed from
literature, then we describe the enrichment analysis we
have conducted to show the relevance of identiﬁed genes
to EMT.
Conﬁrmed interactions and bio-markers for EMT
Previous studies [33,53,54] have demonstrated that the
miR-200 family targets the E-cadherin transcriptional
repressors zinc ﬁnger E-box binding homeobox 1(ZEB1)
and ZEB2 for EMT. These results have conﬁrmed the
Figure 5 Network motif. Feed Forward Loop network motifs are extracted from the integrated global network. The genes identiﬁed in these
network motifs are signiﬁcantly enriched for biological functions of EMT.
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interactions found using our method (shown in Figure 3),
where we see that the hsa-miR-200 family (miR-200a,
miR-200b, miR-200c, miR-429) regulates both ZEB1 and
ZEB2. These interactions are the important interac-
tions that are involved in the process of inhibition and
induction of EMT. Figure 6 shows the process in detail
where genes identiﬁed by our method are marked with
red bars.
Apart from the miR-200 family, several important tran-
scription factors that act as the bio-markers for EMT
are also conﬁrmed by our method. The two transcrip-
tion factors, ZEB1 and ZEB2, which are regulated by the
miR-200 family, are the markers in all three subtypes of
EMT [55]. Another transcription factor that plays a cru-
cial role in EMT is SNAI2 (SLUG). In fact, all known EMT
events during development, cancer, and ﬁbrosis appear
Figure 6 The pathway of development microRNA-dependent inhibition of EMT. Genes identiﬁed by our method are marked with red bars.
miR-200 family regulates ZEB1 and ZEB2 in the process of inhibition and induction of EMT. These interactions are also identiﬁed by our method.
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to be associated with SNAI activation [56]. Our results
suggest that SNAI2 indirectly regulates ZEB1 and ZEB2
by regulating the miR-200 family transcript (Figure 4), and
in turn the miR-200 family regulates ZEB1 and ZEB2 (see
Figure 3). This result is consistent with the literature as
SNAI2 is conﬁrmed to regulate the miR-200 family [57].
The other EMT bio-marker identiﬁed by our method is
ETS1 (see Figure 4). It has been suggested that ETS1 is an
upstream regulator of ZEB1 and ZEB2 [58], and therefore
plays a critical role in activating the regulation of EMT.
Functions of identiﬁed genes being highly enriched for
EMT
The functions of the identiﬁed genes (in Figures 3, 4, and
5) and the pathways which the genes potentially consti-
tute are analysed using GeneGo Metacore from GeneGo
Inc. and the Ingenuity Pathway Analysis (IPA, Ingenu-
ity Systems, www.ingenuity.com). The genes identiﬁed as
a result of the network inference step are signiﬁcantly
enriched for several biological functions. The top func-
tions output from IPA that are known to be critical for
EMT are gene expression, cellular development, cellu-
lar growth and proliferation, cellular movement, and cell
death. Moreover, several genes belong to the classes of
invasion and migration. These classes are sub-categories
of cellular movement, and they have been conﬁrmed as
the functional markers of EMT [59]. This suggests that
many target genes and their interactive regulators are
involved in EMT. Table 1 shows the genes in the class of
invasion and migration together with their p-values.
In addition, the pathways which the genes in our
results potentially constitute are identiﬁed using GeneGo
Table 1 Identiﬁed genes are signiﬁcantly involved in the
functional markers of EMT
Functions Molecules Number p-value
Invasion VDR, FGF8, miR-17-5p, 16 1.26E-06 -
5.4E-03
miR-200a-3p, miR-429, miR-7-5p
TIMP1, CDX2, ETS1, FLNA,
FOSL1, SPDEF, TNK2, YY1
ZEB1, ZEB2.
Migration ESRRA, ETS1, FOSL1, 24 3.59E-09 -
7.96E-03
PRKD1, SNAI2, SPDEF, TIMP1,
TNK2, ABL2, CDX2, FGF8,
FLNA, GRB7, let-7a-5p, miR-16-5p,
miR-17-5p, miR-200a-3p, miR-429,
NFIC, PRAP1, PTPRU, RXRA,
SREBF1, ZEB1
A signiﬁcant number of genes identiﬁed in the inference step belong to the
class of invasion and migration which are EMT functional markers. The results
are generated by IPA.
Metacore. The statistically mapped pathways show that
they are highly relevant to EMT. There are direct path-
ways that regulate EMT, such as the pathway of devel-
opment microRNA-dependent inhibition of EMT. This
pathway shows the regulation of the miR-200 family
and other miRNAs on the EMT bio-markers ZEB1 and
ZEB2, and results in the inhibition and induction of EMT.
Figure 6 shows the details of this pathway. Other direct
pathways such as the development TGF-beta-dependent
induction of EMT via SMADs, and cell adhesion tight
junctions, are known to play critical roles in the regulatory
procedure of EMT. The summary of these pathways and
the corresponding p-values are given in Table 2.
Discussion
During the past few decades, considerable eﬀorts have
been made to explore the transcriptional regulatory net-
works in which transcription factors play the role as a
main regulator. Other recent studies have investigated the
post-transcriptional regulatory networks with miRNAs as
the main regulator. However, with the ultimate goal of
achieving a profound understanding of the mechanisms
that control gene activities, it is sensible and desirable
to ﬁnd regulatory relationships involving both types of
regulators from diverse sources of data.
In this paper, we utilise Bayesian network learning in
constructing the network, but the integrated global net-
work in general is not a Bayesian network. For instance,
one of the requirements for Bayesian networks is that
the network structure must be a Directed Acyclic Graph
(DAG). Our integrated global network may include some
loops of interactions where two regulators interact with
each other, hence it is not a Bayesian network. Such
cyclic network behaviour is more reasonable in real-
ity, as more and more feedback loops between miRNAs
and TFs are being reported. For instance, the ZEB/miR-
200 pair is a feedback loop that regulates EMT [60].
Therefore, the integrated global network may provide
more information than normal Bayesian networks which
are DAGs.
In the network inference step, we use network motif
ﬁnding algorithm to discover the sub-networks that recur
at statistically signiﬁcant level. Interestingly, the results
from these small sub-networks still retain several impor-
tant interactions and molecules relevant to the biological
condition of the dataset. The relationships between the
signiﬁcance in frequency of graphs and biological func-
tions are still open and interesting research topics. In the
dataset used in this paper, the results are supportive for
this hypothesis. An advantage of motif ﬁnding is that it
produces a manageable number of interactions that can
be used for further experimentation. The results from this
paper, therefore, can provide good resources for future
validating experiments.
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Table 2 The statistically mapped pathways for EMT involve identiﬁed genes
# Pathway p-value
1 Development microRNA-dependent inhibition of EMT 8.645E-17
2 Development WNT signaling pathway. Part 2 2.227E-05
3 Development TGF-beta-dependent induction of EMT via SMADs 7.325E-05
4 Cell adhesion Chemokines and adhesion 4.632E-04
5 Cell adhesion Tight junctions 1.614E-03
6 Cell adhesion Role of tetraspanins in the integrin-mediated cell adhesion 1.748E-03
7 Development TGF-beta receptor signaling 4.154E-03
The mapped pathways involve identiﬁed genes that are important for EMT. The results are generated by GeneGo Metacore.
While the networkmotifs found based on the regulatory
network may provide useful patterns to guide biologi-
cal experiments, these motifs depend on the structure of
the regulatory network. The structure of the regulatory
network in this paper is obtained based on the assump-
tion that miRNAs and TFs are regulators and mRNAs
are targets. However, the knowledge of gene regulatory
relationships is still limited and the assumption may not
always hold in reality. When the structure of the regula-
tory network changes the resulting network motifs may
change too.
In the paper, we use the diﬀerentially expressed genes
as the nodes for the gene regulatory network. We assume
that genes whose expression levels do not change signif-
icantly between conditions would not play an important
role in the regulatory network. There may be the case
that a gene is the target of two regulators that cancel
out each other, resulting in the expression level of the
target gene unchanged. However, to make our method
computationally practical we do not consider such cases.
To start the process of Bayesian network structure
learning, target information is used to initialise the net-
work. The target information based on sequence data
may involve false discoveries. Bayesian network struc-
ture learning uses gene expression data to evaluate the
conﬁdence level of each interaction (edge) in the initial
network, and only the interactions of high conﬁdence
are integrated into the global network. Therefore, graph-
ically the set of edges in the global network is a subset
of the set of edges in the initial network. The enrich-
ment analysis shows that the important interactions for
EMT are retained in the global network, demonstrating
the eﬀectiveness of the method. Other high-conﬁdence
interactions provide strong hypotheses for experimental
validations.
Conclusions
In this study, we have proposed a framework for inferring
complex gene regulatory networks using diverse sources
of data, including target information for regulators,
expression proﬁles, and sample categories. The interplay
between regulators and the motifs with which they reg-
ulate target genes are revealed in the three-component
network, and it is impossible to infer the interplay from
any single regulator regulatory networks. The analysis of
the EMT datasets has produced several results that have
been validated by literature, a number of statistically sig-
niﬁcant interactions between miRNAs and TFs, and novel
network motifs.
Additional ﬁles
Additional ﬁle 1: Diﬀerentially expressed miRNAs, TFs, andmRNAs.
limma package from Bioconductor is used to identify diﬀerentially
expressed miRNAs, TFs, and mRNAs.
Additional ﬁle 2: Target information. The interactions that show the TF
and miRNA target information. This information is used to initialise the
searching space for Bayesian network learning.
Additional ﬁle 3: Signiﬁcant interactions. All the statistically signiﬁcant
interactions for the complex three-component network. These interactions
represent the regulatory relationships between miR-mRNA, miR-TF,
TF-miRNA, TF-TF, and TF-mRNA.
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